MUMBAI: Cardiovascular medical device manufacturer Sahajanand Medical Technologies (SMT) has appointed Bhargav Kotadia as chief executive officer and Jose Calle Gordo as chairman, effective 1 April 2025.
Kotadia succeeds Ganesh Sabat, who is stepping down after 12 years at the helm. Company founder Dhirajlal Kotadia will transition to chairman emeritus, whilst continuing to provide strategic guidance.

The incoming chief executive has been closely involved with SMT's strategic direction for the past 12 years. "Our goal remains clear: to innovate, expand, and make a meaningful impact in global cardiovascular care," said Kotadia.

Gordo, the newly appointed chairman, expressed confidence in the leadership change: "Bhargav's deep understanding of the industry, combined with his strategic vision, will drive SMT's continued growth and leadership in cardiovascular technologies."

SMT, which operates in more than 80 countries, specialises in drug-eluting stents and structural heart disease solutions. The company is known for pioneering biodegradable polymers in cardiovascular treatments.